ГоловнаArchive of numbers2021Volume 29, issue 2 (107)Contemporary views on disorders of neuromiyelitis optica spectrum. Clinical case from personal practice
Title of the article Contemporary views on disorders of neuromiyelitis optica spectrum. Clinical case from personal practice
Authors Shkrobot Svitlana
Budarna Olena
Duve Khrystyna
Tkachuk Nataliya
Milevska-Vovchyk Lyubov
In the section HELP TO PRACTICAL PHYSICIAN
Year 2021 Issue Volume 29, issue 2 (107) Pages 90-94
Type of article Scientific article Index UDK 616.831-005.4-036.1:616.155.3 Index BBK -
Abstract DOI: https://doi.org/10.36927/2079-0325-V29-is2-2021-15 Neuromyelitis optica (Devic’s disease) is a demyelinating disease of central nervous system. This disease is progressive and might be fatal. The authors have analyzed data of domestic and foreign literature on research issue. The idea of modern laboratory and instrumental survey methods was summarized, because clinical manifestation of the disease may be non-specific and differential searching might be extremely wide. The modern schemes of treatment of described syndrome are represented. As an illustration we used own clinical observation confirmed by the results of neuroimaging. The practical orientation of the represented scientific report is proved.
Key words neuromiyelitis optica, differential diagnosis, antibodies to aquaporin-4, demyelinating diseases
Access to full text version of the article pdf download
Bibliography 1. Mironenko T. V., Hubetova I. V. Optikomielit (bo¬lezn Devika). Nauchnyiy obzor i sobstvennoe klinicheskoe nablyudenie // Mezhdunarodnyiy nevrologicheskiy zhurnal. 2015. № 1 (71). S. 141—147. 2. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders / Wingerchuk D. M., Banwell В., Bennett J. [et al.] // Neurology. 2015; 85(2): 177—189. DOI: 10.1212/WNL.0000000000001729. 3. Comparison of relapse and treatment failure rates among patients with neuromyelitis optica: Multicenter study of treatment efficacy / M. A. Mealy, D. M. Wingerchuk, J. Palace [et al.] // JAMA Neurol. 2014 Mar; 71(3): 324—30. DOI: 10.1001/jamaneurol.2013.5699. 4. Antibody to aquaporin-4 in the long-term course of neu¬romyelitis optica / Jarius S., Aboul-Enein F., Waters P. [et al.] // Brain. 2008; 131: 3072—3080. DOI: 10.1093/brain/awn240. 5. Damato V. V., Evoli A., Iorio R. Efficacy and safety of rituximab therapy in neuromyelitis optica spectrum disorders: A systematic review and meta-analysis // JAMA Neurol. 2016. Vol. 73. P. 1342—1348. DOI: 10.1001/jamaneurol.2016.1637. 6. The spectrum of neuromyelitis optica / Wingerchuk D. M., Lennon V. A., Lucchinetti C. F. [et al.] // Lancet Neurol. 2007; 6: 805—815. URL: https://www.orpha.net/data/patho/Pro/en/NeuromyelitisOptica-ENenPro10986.pdf. 7. Matiello M., Weinshenker B. G. Neuromyelitis optica. Chapter 13 Part of Multiple Sclerosis / Ed.: C. F. Lucchinetti, R. Hohlfeld // In: Blue Books of Neurology. 2010. Vol. 35. P. 258—275. DOI: https://doi.org/10.1016/B978-1-4160-6068-0.00013-9. 8. Brain magnetic resonance imaging findings in relapsing neuromyelitis optica / Cabrera-Yomez J. A., Quevedo-Sotolongo Z., González-Quevedo A. [et al.] // Mult. Scler. 2007. Vol. 13. P. 186—192. DOI: 10.1177/1352458506070725. 9. Mariotto S., Ferrari S., Monaco S. Clinical spectrum and IgG subclass analysis of antimyelin oligodendrocyte glycoprotein antibody associated syndromes: a multicenter study // J Neurol. 2017 Dec; 264(12): 2420—30. DOI: 10.1007/s00415-017-8635-4. 10. Belova A. N., Boyko A. N., Belova E. M. Diagnosticheskie kriterii optikomielit-assotsiirovannyih rasstroystv // Zhurnal nevrologii i psihiatrii. 2016, № 2, vyip. 2. S. 32—40. DOI: 10.17116/jnevro20161162232-40. 11. Treatment of Neuromyelitis Optica: Review and Recommendations / Kimbrough D., Fujihara K., Jacob A. [et al.] // Mult Scler Relat Disord. 2012; 1: 180—187. DOI: 10.1016/j.msard.2012.06.002. 12. Maintenance plasma exchange therapy for steroid-refractory neuromyelitis optica / B. O. Khatri, J. Kramer, M. Dukic [et al.] // J. Clin. Apher. 2012. Vol. 27. P. 183—192. DOI: 10.1002/jca.21215. 13. Pittock S. Y., Zennon V. A., Krecke K. Brain abnormalities in neuromyelitis optica // Arch. Neurol. 2006. Vol. 63. Р. 390—396. DOI: 10.1001/archneur.63.3.390. 14. Epidemiology of Neuromyelitis Optica in the World: A Systematic Review and Meta-Analysis / Etemadifar M., Nasr Z., Khalili B. [et al.] // Mult Scler Int. 2015. Vol. 2015: ID 174720. DOI: 10.1155/2015/174720. 15. Bakulin I. S., Simaniv T. O., Konovalov R. N., Zaharova M. N. Porazhenie area postrema kak prichina neukrotimoy ikotyi, toshnotyi i rvotyi pri zabolevaniyah optikomielitnogo spektra (nablyudenie iz praktiki). Zhurnal nevrologii i psihiatrii im. S. S. Korsakova. Spetsvyipuski. 2017; 117 (10-2). S. 20—23. DOI: 10.17116/jnevro201711710220-23.